AUTL vs ECL · rev $10.1M vs P/E 35, rev $4.01B
Autolus Therapeutics Ltd (AUTL) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Autolus Therapeutics Ltd (AUTL) is a biotechnology company listed on US.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported AUTL revenue for 2024-12-31 was $10.1M. Net income was -$220.7M. Revenue was up 496.0% from 2023-12-31 to 2024-12-31. AUTL currently screens at market cap $614.8M.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
AUTL currently screens at market cap $614.8M. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the AUTL and ECL stock pages for the full models.
Not investment advice.